| Cat. No. |
Product Name |
Information |
| PC-25293 |
LXE408
Kinetoplastid proteasome inhibitor
|
Galeflaprit (LXE408) is a potent, selective inhibitor of the kinetoplastid proteasome with IC50 of 0.04 uM (L. donovani proteasome), inhibits L. donovani amastigote proliferation within primary mouse macrophages (IC50=0.04 uM). |
| PC-25200 |
BKI-1708
CpCDPK1 inhibitor
|
BKI-1708 is a highly potent, specific Cryptosporidium calcium-dependent protein kinase 1 (CDPK1) inhibitor with IC50 of 0.7 nM (CpCDPK1, C. parvum CDPK1) and EC50 of 0.4 uM against C. parvum parasites in Nanoluciferase assays. |
| PC-25005 |
ZY-19489
Antimalarial
|
Sutidiazine (Zintrodiazine, ZY-19489, MMV 253, AZ-13721412) is a novel antimalarial triaminopyrimidine compound with IC50 of 9 nM against sexual blood stage of Plasmodium falciparum (Pf). |
| PC-24759 |
BKI-1748
CDPK1 inhibitor
|
BKI-1748 a small molecule bumped kinase inhibitor targeting calcium dependent protein kinase 1 (CDPK1), inhibits TgCDPK1 and NcCDPK1 enzyme activities at low nM-concentrations, inhibits proliferation of apicomplexan parasites with EC50 of 165 nM for N. caninum and 43 nM for T. gondii. |
| PC-23461 |
VCC234718
Mtb GuaB2 inhibitor
|
VCC234718 isa potent, specific small molecule inhibitor of Mtb inosine-5′-monophosphate dehydrogenase (IMPDH) GuaB2 with Ki of 100 nM, shows growth inhibitory activity against Mycobacterium tuberculosis (Mtb H37Rv, MIC90=2 uM). |
| PC-23131 |
EDI048
Cryptosporidium PI4K inhibitor
|
EDI048 (EDI-048) is a specific, ATP-competitive, gastrointestinal-targeted Cryptosporidium PI(4)K (CpPI(4)K) inhibitor with IC50 of 4 nM, >300-fold with human orthologue HsPI(4)K, demonstrates in vitro anti-Cryptosporidium activity (Cp CPE, EC50=52 nM). |
| PC-22969 |
UCT594
Pf PI4K inhibitor
|
UCT594 is a highly potent, selective Plasmodium phosphatidylinositol 4-kinase (PI4K) inhibitor, inhibits the P. vivax PI4K enzyme with IC50 of 24 nM, >200-fold selective over human PI4Kβ ortholog. |
| PC-22800 |
SW584
Pf20Sβ5 inhibitor
|
SW584 is a potent, species-selective, orally active inhibitor of P. falciparum proteasome β5 active site (Pf20Sβ5) with IC50 of 5.8 nM, shows antimalarial activity with EC50 of 3 nM (Pf3D7 and PfDd2). |
| PC-22743 |
MMV1580853
Antimalarial
|
MMV1580853 (BPH-1358) is a potent and exceedingly fast-acting blood-stage antimalarial, inhibits human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor with IC50s of 1.8 μM and 110 nM, respectively, is active against S. aureus in vitro (MIC, 250 ng/mL). |
| PC-22373 |
MMV1557817
Aminopeptidase M1/M17 inhibitor
|
MMV1557817 is a selective, nanomolar inhibitor of both Plasmodium falciparum and Plasmodium vivax aminopeptidases M1 (Ki=308/19 nM) and M17 (Ki=112/208 nM), demonstrates potent activity against asexual and sexual stage parasites. |
| PC-21960 |
NF2839
SmHDAC8 inhibitor
|
NF2839 is a quinolone-based HDAC inhibitor with IC50 of 0.1 uM for S. mansoni HDAC8 (SmHDAC8), inhibits S. mansoni larval stage with LD50 of 10.6 uM. |
| PC-21553 |
TDI-8304
Pf20S inhibitor
|
TDI-8304 is a highly selective, macrocyclic peptide inhibitor of malaria parasite Plasmodium falciparum proteasome (Pf20S) with IC50 of 0.06 uM, shows high potency against P. falciparum strain Pf 3D7 (EC50=0.009 uM). |